权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Cholesterol Regulation of Endothelial K+ Channels

内皮 K 通道的胆固醇调节

基本信息

批准号：
10836797
负责人：
Irena Levitan
金额：
$ 8.26万
依托单位：
UNIVERSITY OF ILLINOIS AT CHICAGO
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-12-06 至 2025-05-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10836797
关键词：
Address Aorta Apolipoprotein E Atherosclerosis Binding Binding Sites Biochemical Blood Vessels Cardiovascular Diseases Cell Line Cells Cessation of life Cholesterol Clustered Regularly Interspaced Short Palindromic Repeats Complex Cytoskeleton Data Dependovirus Descending aorta Development Down-Regulation Dyslipidemias Electrophysiology (science)Endothelial Cells Endothelium Functional disorder Funding Gene Expression Genetic Goals Grain Grant High Density Lipoproteins Human Hydrophobicity Impairment In Vitro Individual Injury Ion Channel KDR gene Kir2.1 channel Lesion Low-Density Lipoproteins Mediating Modeling Molecular Monomeric GTP-Binding Proteins Morbidity - disease rate Mus Mutation Neutrons PECAM1 gene PIK3CG gene Phenotype Phospholipids Phosphorylation Plasma Play Potassium Channel Process Proteins Radiolabeled Regulation Research Risk Factors Role Signal Transduction Site-Directed Mutagenesis Testing Thinness Transgenic Model Transgenic Organisms Translating Transmembrane Domain Vasodilation Woman atheroprotective computer studies endothelial dysfunction gain of function hypercholesterolemia in vivo insight inward rectifier potassium channel loss of function men molecular dynamics molecular scale mouse model mutant novel novel therapeutic intervention overexpression predictive modeling response simulation transcriptome sequencing

项目摘要

Dyslipidemia-induced endothelial dysfunction plays a major role in the initiation of atherosclerosis. Our studies discovered that plasma hypercholesterolemia results in suppression of endothelial inwardly- rectifying K+ (Kir) channels and that Kir channels play a major role in endothelial response to flow. Our long term goal is to elucidate the mechanisms responsible for cholesterol-induced regulation of endothelial ion channels and determine the impact of cholesterol-induced suppression of Kir on vascular function and atherosclerosis development. During the previous funding period of this grant, we discovered a new mode of cholesterol-Kir2 interactions via multiple dynamic contacts, provided direct evidence that Kir2.1 plays a crucial role in flow-induced vasodilation and NO release, and showed that hypercholesterolemia-induced impairment of flow-induced vasodilation can be attributed to Kir2.1 suppression. In the current proposal, we extend these studies to address three new goals: In Aim 1, we address the fundamental question of how cholesterol binding to the specific binding sites that we have already identified translates into the inhibition of channel gating. Specifically, we address a novel hypothesis based on our computational studies predicting that cholesterol binding uncouples specific residues within the channels, crucial for the gating process. This hypothesis will be addressed using a combination of multi-scale Molecular Dynamics simulations, a state-of-the-art computational approach, followed by site-directed mutagenesis, functional analysis of the channel function by high throughput electrophysiology, and biochemical and neutron scattering studies to evaluate direct cholesterol interactions with Kir2 channels. In Aim 2, we will extend our studies to determine the role of cholesterol suppression of Kir2.1 in two major endothelial flow responses: 1) activation of PECAM1/Src/VEGFR2/PI3K/Akt signaling axis and 2) cytoskeleton remodeling. This aim is based on our RNA sequencing analysis that revealed a major role of Kir2.1 in flow-sensitive gene expression including the expression of PECAM1/VEGFR2 mechanosensor complex. Specifically, we will test the hypothesis that suppression of endothelial Kir channels by hypercholesterolemic conditions impairs flow-induced activation of VEGFR2 and activation of a small GTPase, RhoA, and alters flow-induced cytoskeletal remodeling. Finally, in Aim 3, we will determine the role of endothelial Kir2.1 in lesion formation of dyslipidemic mice. We have already established that the global deficiency of Kir2.1 exaggerates lesion formation in dyslipidemic ApoE-/- mice. In the proposed study, we will determine if the effect is specific for endothelial Kir2.1. Furthermore, we will also employ a new model of Kir2.1 rescue, a transgenic CRISPR mouse that expresses a cholesterol-insensitive Kir2.1 mutant. We believe that taken together, these studies will make a significant contribution to the understanding of cholesterol regulation of ion channels, dyslipidemia-induced endothelial dysfunction, and the mechanisms of lesion formation.

血脂异常诱导的内皮功能障碍在动脉粥样硬化的发生中起重要作用。我们研究发现，血浆高胆固醇血症导致内皮细胞向内的抑制，整流K+（Kir）通道，并且Kir通道在内皮对流动的反应中起主要作用。我们漫长长期的目标是阐明负责胆固醇诱导的内皮离子调节的机制，通道，并确定胆固醇诱导的Kir抑制对血管功能的影响，动脉粥样硬化的发展在上一个资助期内，我们发现了一个新的模式，胆固醇-Kir 2相互作用通过多个动态接触，提供了直接证据，Kir2.1发挥作用，在血流诱导的血管舒张和NO释放中起关键作用，并表明高胆固醇血症诱导的血流诱导的血管舒张的损害可归因于Kir2.1抑制。在目前的提案中，我们扩展这些研究，以解决三个新的目标：在目标1，我们解决的基本问题，如何胆固醇与我们已经确定的特异性结合位点结合，通道门控。具体来说，我们根据计算研究提出了一个新的假设预测胆固醇结合会使通道内的特定残基解偶联，这对于门控至关重要。过程这一假设将使用多尺度分子动力学的组合来解决模拟，一个国家的最先进的计算方法，其次是定点诱变，功能通过高通量电生理学、生物化学和中子分析通道功能散射研究，以评价胆固醇与Kir 2通道的直接相互作用。在目标2中，我们将扩展我们的确定Kir2.1的胆固醇抑制在两种主要内皮血流反应中的作用的研究：1） PECAM 1/Src/VEGFR 2/PI 3 K/Akt信号传导轴的激活和2）细胞骨架重塑。该目的是基于我们的RNA测序分析，揭示了Kir2.1在流量敏感基因中的主要作用，表达包括PECAM 1/VEGFR 2机械传感器复合物的表达。具体来说，我们将测试高胆固醇血症条件抑制内皮Kir通道损害流动诱导的VEGFR 2激活和小GT3，RhoA的激活，并改变流动诱导的细胞骨架重塑最后，在目标3中，我们将确定内皮Kir2.1在损伤形成中的作用。血脂异常的老鼠。我们已经确定Kir2.1的全面缺乏会加重病变在血脂异常的ApoE-/-小鼠中形成。在拟议的研究中，我们将确定这种影响是否针对内皮细胞Kir2.1。此外，我们还将采用一种新的Kir2.1拯救模型，即转基因CRISPR。表达胆固醇不敏感Kir2.1突变体的小鼠。我们相信，这些研究综合起来，将对理解胆固醇对离子通道的调节做出重大贡献，血脂异常诱导的内皮功能障碍，以及病变形成的机制。

项目成果

期刊论文数量（7）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

The effect of cellular cholesterol on membrane-cytoskeleton adhesion.

细胞胆固醇对膜细胞骨架粘附的影响。

DOI：
10.1242/jcs.001370
发表时间：
2007
期刊：
Journal of cell science
影响因子：
4
作者：
Sun,Mingzhai;Northup,Nathan;Marga,Francoise;Huber,Tamas;Byfield,FitzroyJ;Levitan,Irena;Forgacs,Gabor
通讯作者：
Forgacs,Gabor

On, in, and under membrane.

膜上、膜内和膜下。